Accent Microcell

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Q5D01013
  • NSEID: ACCENTMIC
  • BSEID:
INR
334.10
-4.4 (-1.3%)
BSENSE

Dec 19

BSE+NSE Vol: 25000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.77% vs 24.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 6.17% vs 108.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -69.85% vs -54.77% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 9.60% vs 146.63% in Mar 2024

Compare Profit and Loss Results of Accent Microcell
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
264.00
79.00
185.00
234.18%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
264.00
79.00
185.00
234.18%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
0.00
-3.00
0%
Raw Materials Consumed
165.00
35.00
130.00
371.43%
Power & Fuel Cost
20.00
0.00
20.00
0%
Employee Cost
15.00
9.00
6.00
66.67%
Operating Expenses
9.00
2.00
7.00
350.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
0.00
9.00
0%
Cost of Software developments
0.00
1.00
-1.00
-100.00%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
222.00
53.00
169.00
318.87%
Operating Profit (PBDIT) excl Other Income
41.00
25.00
16.00
64.00%
Other Income
6.00
2.00
4.00
200.00%
Operating Profit (PBDIT)
48.00
28.00
20.00
71.43%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
47.00
28.00
19.00
67.86%
Depreciation
4.00
1.00
3.00
300.00%
Profit Before Taxation & Exceptional Items
43.00
26.00
17.00
65.38%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
43.00
26.00
17.00
65.38%
Provision for Tax
10.00
6.00
4.00
66.67%
Profit After Tax
33.00
19.00
14.00
73.68%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
65.00
29.00
36.00
124.14%
Profit Available for appropriations
98.00
49.00
49.00
100.00%
Appropriations
98.00
49.00
49.00
100.00%
Equity Dividend (%)
10%
15%
-5.00
Earnings Per Share
15.71
33.75
-18.04
-53.45%
Profit And Loss - Net Sales
Net Sales 264.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.77% vs 24.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.17% vs 108.28% in Mar 2024

Profit And Loss - Interest
Interest 0.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -69.85% vs -54.77% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 33.06 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.60% vs 146.63% in Mar 2024